Pharmaceutical distributor launches $150 million venture fund
AmerisourceBergen, one of the top pharmaceutical distributors, is investing $150 million in a corporate venture fund focused on healthcare start-ups.
The wholesale giant’s new fund, called AB Health Ventures, will initially look to invest in early to mid-stage health-related start-ups in the U.S. and abroad. The fund will prioritize investments in start-ups focused on innovation in pharmacy and distribution, clinical development and commercialization of pharmaceuticals, and practice solutions for healthcare providers and animal health, executives said in a press release.
Touchdown Ventures, a firm specializing in corporate venture capital, will help manage the AB Health Ventures fund and, in that process, work closely with senior executives of AB in all aspects of operating the fund.
